Govt to back phase-3 trials, manufacture of Russian vaccine: NITI Aayog

Aayog member V K Paul said Indian scientists have studied Russian vaccine data and assessed a need for phase-3 trial which can be facilitated by govt as per Indian rules

The Centre is in discussions with Russia to pave the way for phase-3 trials and scale up the manufacture of the Sputnik V vaccine for coronavirus developed by Moscow-based Gamaleya Institute in India, V K Paul, member-health, NITI Aayog said on Tuesday. 

“The Government of India attaches great importance to this offer of a partnership from a friend, who is a very special friend to this nation...Outreach has been extended to several companies in India and many have come forward,” he said while addressing a briefing on Covid situation in India. 

Paul said that Russia had sought India’s help to